
The first reported case of an X-chromosome variant detected by NIPT, confirmed by karyotyping but missed by FISH, involved Savitha (name changed), a 24-year-old woman from Delhi who was pregnant with her first child. She was referred for non-invasive prenatal testing (NIPT) after her biochemical screening indicated a high risk.
The Claria NIPT results showed a low risk for trisomies 21, 18, and 13, but indicated a high risk of monosomy X (Turner syndrome). She was therefore advised to undergo confirmatory amniocentesis. The fluorescence in situ hybridisation (FISH) report showed no numerical abnormalities in any of the five chromosomes tested. In view of the discordant results, the sample was re-tested by NIPT to rule out any laboratory error. The repeat NIPT result was consistent with the initial finding.
Three weeks later, the karyotype analysis confirmed the presence of a rare variant of Turner syndrome.

This is possibly the first reported case of a prenatal chromosomal abnormality of chromosome X that was detected by NIPT, missed by FISH, and confirmed by karyotyping. Claria NIPT uses a single nucleotide polymorphism (SNP)-based method of analysis. The high sensitivity and specificity of this SNP-based technique enabled the detection of a rare variant of Turner syndrome.
*Eswarachari V, et al. Noninvasive prenatal testing (NIPT) detects variant of Turner syndrome not detectable by fluorescent in situ hybridization. J Matern Fetal Neonatal Med. 2018 Jun 13:1-4.
MedGenome offers the most accurate non-invasive prenatal screening test (NIPT), genetic carrier screening, preimplantation genetic screening/diagnosis (PGS/PGD) and product of conception testing.
Additionally, MedGenome offers an on-demand pre and post-test genetic counselling to all patients.
| MedGenome Offers | Test Sample Requirements | Required Forms | Reporting Time |
| NIPT for common aneuploidies T21, T18, T13 Sex Chromosome abnormalities, triploidy. | |||
| NIPT for 5 common clinically relevant microdeletions: 22q11.2 deletion syndromes, 1p36 deletion syndrome, Prader-Willi syndrome, Cri-du-chat syndrome. | ![]() 20 ml peripheral blood in Streck tubes | Relevant clinical information, including all the clinical presentations and symptoms. | 10 to 16 working days |
| NIPT for screening for twin, egg donor, and surrogate pregnancies. |
MedGenome offers highly accurate genetic testing services, including Non-Invasive Prenatal Testing (NIPT), Genetic Carrier Screening, Preimplantation Genetic Screening and Diagnosis (PGS/PGD), as well as Product of Conception (POC) testing. In addition, MedGenome provides on-demand genetic counselling both before and after testing for all patients.
Preimplantation Genetic Screening
Day 5 (few cells) embryon biopsy or Day3 (single cell)
Informed Consent Form & Test Requisition Form
7 working days


At MedGenome, scientific experts drive the development of innovative omics solutions that enable early detection of complex diseases. With advanced global-quality next-generation sequencing and proprietary analysis pipelines, the team consistently delivers tests and services that are transforming the way diseases are diagnosed and treated.
Sy. Nos. 94/1C and 94/2, Tower 1, Ground Floor, Veerasandra Village, Attibele Hobli, Electronic City Phase-1, Electronics City, Bangalore, Bangalore South, Karnataka, India, 560100 Toll free number: 1800 296 9696
*Explore our range of CAP-accredited tests- Click to know more